Month: September 2025

HAMPTON, N.J., Sept. 09, 2025 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced that management will participate in a fireside chat today, September 9th, 2025, at the Morgan Stanley 23rd Annual Global Healthcare Conference at 3:20 pm ET. A live webcast of the presentation will be available on the “Events & Presentations” page of the “Investors” section of the Celldex website. A replay will be available for 90 days following the event. About CelldexCelldex is pioneering new horizons in immunology to deliver life-changing therapies. We are relentless in our pursuit of novel antibody-based treatments that engage the human immune system and directly affect critical pathways to improve the lives of patients with allergic, inflammatory and autoimmune disorders. Visit www.celldex.com. Company...

MCLEAN, Va., Sept. 09, 2025 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) announced today the pricing of its second Seasoned Credit Risk Transfer Trust (SCRT) offering of 2025—a securitization of approximately $707 million including both guaranteed senior and non-guaranteed subordinate securities backed by a pool of seasoned re-performing loans (RPLs). The SCRT program is a fundamental part of Freddie Mac’s seasoned loan offerings which reduce less-liquid assets in its mortgage-related investments portfolio and shed credit and market risk via economically reasonable transactions. Freddie Mac Seasoned Credit Risk Transfer Trust, Series 2025-2 includes approximately $673 million in guaranteed senior certificates and $34 million in non-guaranteed mezzanine and subordinate certificates. The transaction is expected to settle on...

SAN DIEGO, Sept. 09, 2025 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today issued a statement regarding the U.S. Food and Drug Administration’s (FDA) public posting of its Complete Response Letter (CRL) for the Biologics License Application (BLA) for Deramiocel, the Company’s investigational cell therapy for the treatment of cardiomyopathy associated with Duchenne muscular dystrophy (DMD). The Company was not notified in advance that the CRL would be posted, but acknowledges the FDA’s decision to publish the letter, originally received in July 2025. However, the FDA did not release the comprehensive preliminary response that Capricor submitted shortly after receipt of the CRL. This written response provided clarifications...

The Launch is Accompanied by Entry into Commitment Letter for New SEK 750 million Super Senior Revolving Credit Facility and Agreements for Repurchase and Cancellation of Certain Convertible Senior PIK Notes due 2028 MALMÖ, Sweden, Sept. 09, 2025 (GLOBE NEWSWIRE) — Oatly Group AB (Nasdaq: OTLY) (“Oatly” or the “Company”) announced today that it (i) will participate in a series of investor meetings to pursue the issuance of SEK denominated senior secured floating rate bonds (the “Nordic Bonds”), (ii) has entered into a commitment letter for a new SEK 750 million super senior revolving credit facility contemplated to become effective following settlement of the Nordic Bonds, and (iii) has entered into Convertible Note Repurchase Agreements (the “Repurchase Agreements”) with certain holders (the “Selling Noteholders”) of our 9.25%...

SARASOTA, FL, Sept. 09, 2025 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced that the Japan Patent Office has granted patent number 7683882 to Silo’s research and licensing partner Columbia University for the invention titled “Prophylactic efficacy of serotonin 4 receptor agonists against stress,” exclusively licensed to Silo by Columbia University. Columbia University recently received an Australian patent for the same invention. The patent reinforces protection for Silo’s lead asset, SPC-15, an intranasal treatment targeting post-traumatic stress disorder (PTSD), originally developed by Columbia University. “This Japanese patent adds another layer of protection for SPC-15, adding to our high-value...

Sanoma Corporation, Stock Exchange Release, 9 September 2025 at 16:05 p.m. EET Sanoma’s financial reporting in 2026 In 2026, Sanoma Corporation will publish financial information as follows: Full-Year Result 2025                                                 Wednesday, 11 FebruaryInterim Report 1 January–31 March 2026                Thursday, 7 MayHalf-Year Report 1 January–30 June 2026               Wednesday, 29 JulyInterim Report 1 January–30 September 2026         Wednesday, 28 October Sanoma practices a silent period of 30 days prior to publishing financial information. Sanoma’s Financial Statements and Directors’ Report for 2025 will be published during week 14, which starts on 30 March 2026. Sanoma Corporation’s Annual General Meeting (AGM) 2026 is planned to be held on Thursday, 7 May 2026 in Helsinki. The Board of Directors...

Company Achieves Consistent Growth With Four Straight Record Months; Gross Margin Expands 2,000+ Basis Points in Three Quarters; Production Hits Strongest Levels to Date West Seneca, New York, Sept. 09, 2025 (GLOBE NEWSWIRE) — Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or the “Company”), a U.S.-based innovator and manufacturer of hybrid and clean energy solutions primarily for the light truck, overlanding, and global consumer goods markets, today reported that July 2025 revenue reached $1.71 million (unaudited), marking the fourth consecutive monthly sales record. In tandem, gross margin expanded to 31% in July, meaning Worksport achieved its year-end 30% margin goal one quarter early. The Company expects a continual upward trend in revenue and gross margin. Operating Momentum and Financial HighlightsFour straight monthly records:April...

Rogers now provides Canadians with three times more coverage than any other carrier Game-changing service connects Canadians to first responders in remote areas across the country TORONTO, Sept. 09, 2025 (GLOBE NEWSWIRE) — Rogers today announced the expansion of Rogers Satellite. With the satellite-to-mobile texting service, Rogers now provides three times more coverage than any other Canadian wireless service provider. Now, when connected to Rogers Satellite, customers can send a text to friends when taking the ferry from Newfoundland to Nova Scotia, fishing off Haida Gwaii or crossing James Bay, with the expansion across bodies of water and along waterways off the Canadian coastline. “We’re proud to expand this ground-breaking technology to Canadians across the country including national parks, remote highways, and waterways,”...

Sanoma Corporation, Stock Exchange Release, 9 September 2025 at 16:00 EET Sanoma’s Board of Directors has decided the record date and payment date of the second instalment of the dividend for 2024 The Board of Directors of Sanoma Corporation has in its meeting decided the record date and payment date of the second instalment of the dividend for 2024, amounting to EUR 0.13 per share. The second dividend instalment shall be paid to a shareholder who is registered in the shareholders’ register of Sanoma Corporation maintained by Euroclear Finland Ltd on the dividend record date 16 September 2025. The dividend payment date for this instalment is 23 September 2025. The Annual General Meeting of Sanoma Corporation held on 29 April 2025 resolved that for 2024 a dividend of EUR 0.39 per share shall be paid in three instalments. The first instalment...